Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Keywords: CELLS ; BLOOD ; CELL ; Germany ; THERAPY ; VIVO ; GENERATION ; SYSTEM ; DISEASE ; POPULATION ; TISSUE ; MARKER ; BIOLOGY ; DISCOVERY ; CELL THERAPY ; MARKERS ; STEM-CELLS ; cord blood ; EXPANSION ; STEM ; FETAL CALF SERUM ; CELL BIOLOGY ; mesenchymal stromal cells ; Genetic ; ANIMAL SERUM ; AUTOLOGOUS SERUM ; BOVINE SERUM ; clinical-scale expansion ; closed process ; CULTURE-CONDITIONS ; good manufacturing practice ; IN-VITRO DIFFERENTIATION ; mononuclear cell separation ; regenerative medicine ; Sepax ; unrestricted somatic stem cell
    Abstract: Background aims. The discovery of unrestricted somatic stem cells (USSC), a non-hematopoietic stem cell population, brought cord blood (CB) to the attention of regenerative medicine for defining more protocols for non-hematopoietic indications. We demonstrate that a reliable and reproducible method for good manufacturing practice (GMP)-conforming generation of USSC is possible that fulfils safety requirements as well as criteria for clinical applications, such as adherence of strict regulations on cell isolation and expansion. Methods. In order to maintain GMP conformity, the automated cell processing system Sepax (Biosafe) was implemented for mononucleated cell (MNC) separation from fresh CB. After USSC generation, clinical-scale expansion was achieved by multi-layered CellSTACKs (Costar/Corning). Infectious disease markers, pyrogen and endotoxin levels, immunophenotype, potency, genetic stability and sterility of the cell product were evaluated. Results. The MNC isolation and cell cultivation methods used led to safe and reproducible GMP-conforming USSC production while maintaining somatic stem cell character. Conclusions. Together with implemented in-process controls guaranteeing contamination-free products with adult stem cell character, USSC produced as suggested here may serve as a universal allogeneic stem cell source for future cell treatment and clinical settings
    Type of Publication: Journal article published
    PubMed ID: 20370349
    Signatur Availability
    BibTip Others were also interested in ...
  • 2
    Keywords: CELLS ; EXPRESSION ; tumor ; BLOOD ; CELL ; Germany ; human ; IN-VIVO ; THERAPY ; VIVO ; FOLLOW-UP ; POPULATION ; GENE ; DRUG ; gene therapy ; MICE ; TRANSDUCTION ; gene transfer ; GENE-TRANSFER ; MARKER ; FLOW ; BIOLOGY ; MATURATION ; TARGET ; HUMANS ; resistance ; VECTOR ; MARKERS ; STEM-CELLS ; FLOW-CYTOMETRY ; HEMATOPOIETIC PROGENITOR CELLS ; HEMATOPOIETIC-CELLS ; PERIPHERAL-BLOOD ; MULTIDRUG-RESISTANCE ; MULTIDRUG-RESISTANCE-1 GENE ; P-GLYCOPROTEIN ; EX-VIVO ; LINEAGE ; RESISTANCE 1 GENE ; SEVERE COMBINED IMMUNODEFICIENCY ; DRUGS ; REPOPULATING CELLS ; in vivo ; progenitor cell ; VARIETIES ; MDR1 gene therapy ; myeloid differentiation ; P-GLYCOPROTEIN EXPRESSION ; peripheral blood ; TRANSDUCED CELLS
    Abstract: Background The objective of multidrug resistance-1 (MDR1) gene therapy is protection of the myeloid cell lineage. It is therefore important to examine the effect of retroviral transduction on myeloid maturation. Transfer of the human MDR1 gene can confer resistance to a variety of cytostatic drugs. For a safe application in humans it is paramount to follow-up the development of transduced cells. Methods We transduced human mobilized peripheral blood progenitor cells (PBPC) with a viral vector containing the human MDR1 cDNA and transplanted the transduced cells into non-obese diabetic severe combined immunodeficient (NOD/SCID) mice. The progeny of the transduced cells was analyzed in detail by flow cytometry. Results A detailed analysis by four-color flow cytometry showed that MDR1 transgene-expressing CD33(+) myeloid cells were preferentially negative for the maturation-associated myeloid markers CD11b and CD10, while the untransduced CD33(+) myeloid cells expressed significantly higher proportions of these Ag (PB 〈 0.01 each). There was no difference in the expression of B- or T-lymphoid Ag among the MDR1-transduced and untransduced lymphoid cells. Discussion These data indicate that retroviral MDR1 gene transfer results in preferential P-glycoprotein expression in myeloid progenitor cells, which is the target cell population for myelotoxicity of cytostatic drugs
    Type of Publication: Journal article published
    PubMed ID: 17148033
    Signatur Availability
    BibTip Others were also interested in ...
  • 3
    Keywords: CANCER ; CELLS ; EXPRESSION ; IN-VITRO ; proliferation ; tumor ; BLOOD ; CELL ; Germany ; DIFFERENTIATION ; MOLECULES ; RELEASE ; ACTIVATION ; DENDRITIC CELLS ; T cell ; T cells ; T-CELL ; T-CELLS ; FLOW ; BIOLOGY ; MOLECULE ; culture ; cytokines ; MATURATION ; STIMULATION ; ASSAY ; NUMBER ; METASTATIC MELANOMA ; PHENOTYPE ; VACCINE ; IMMUNOTHERAPY ; ADAPTIVE IMMUNITY ; FLOW-CYTOMETRY ; INTERFERON-GAMMA ; COLONY-STIMULATING FACTOR ; SURFACE EXPRESSION ; T-cell response ; CYTOKINE ; ELISA ; cancer vaccine ; LEVEL ; methods ; dendritic cell ; microbiology ; coagulation activation ; IL-6 ; MEDICINE ; MONOCYTES ; biotechnology ; E2 ; response ; discussion ; NORWAY ; CELL BIOLOGY ; LIGATION ; red ; CD86 ; DC maturation ; dendritic cell differentiation ; dendritic cell function ; platelet contamination ; T-HELPER-CELLS ; VITRO LIPOPOLYSACCHARIDE-CHALLENGE
    Abstract: Background Monocytapheresis has been established to collect a sufficient number of monocytes (MO) for differentiation to dendritic cells (DC) as a cancer vaccine. Platelets (Plt) are invariably found as a contaminant in the final monocytapheresis product. The aim of this study was to investigate DC differentiation under the influence of Plt with regard to their function and phenotype. Methods MO were isolated and co-cultured with autologous Plt at different MO:Plt ratios (1:1.7, 1:5, 1:15, 1:45 and 1:135) in the presence of interleukin-4 (IL-4) and granulocyte-macrophage colony-stimulating factor (GM-CSF). IL-12p70 release after ligation of CD40L was determined in the supernatant by enzyme-linked immunosorbent assay (ELISA). For T-cell stimulation, tetanus toxoid was added to immature DC and maturation was induced by adding cytokines (IL-1, IL-6, tumor necrosis factor- and prostaglandin E2). Stimulated T cells were analyzed for activation and proliferation as well as for intracellular cytokines by flow cytometry. Results All DC cultures were strongly positive for CD83. At a contaminating concentration of 5 Plt/MO, matured DC showed the highest expression of HLA-DR, CD80 and CD86, inducing a strong T-cell proliferation with high production of IL-4 and interferon-. The highest level of IL-12p70 production was observed by the same DC group. Discussion Plt did not negatively influence DC maturation but enhanced the expression of co-stimulatory molecules and the release of IL-12. Functionally this was reflected by a strong T-cell response that involved T-helper 1 (Th1)- as well as Th2-biased T cells. Our findings show that controlling the Plt concentration may provide important advantages for the generation of DC for use in immunotherapy
    Type of Publication: Journal article published
    PubMed ID: 18985478
    Signatur Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...